Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

K. D. Cummins, S. M. Jane, S. Ninkovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Article numbere246
JournalBlood Cancer Journal
Volume4
Issue number9
DOIs
Publication statusPublished - 1 Jan 2014

Cite this